Parkinson´s disease
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Are older than 50 years of age; Have a diagnosis of PD; In stages I to IV of the Disability Stages of Hoehn & Yahr; Be stable use of anti-parkinsonian; Have good comprehension (assessed using the Mini Mental State Examination score); Signing the informed consent
Exclusion criteria
Exclusion criteria: Adverse medical conditions that may prevent participation in the proposed protocols as decompensated hypertension, neurological diseases or other rheumatic diseases of any kind; Individuals who are in physical therapy for at least 02 months before the randomisation procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected Outcome: Increased muscle strength. Measures of muscle strength will be obtained with a manual dynamometer. Will be assessed maximal isometric force, supported by five seconds, the following muscle groups: the dorsal and plantar flexors and extensors and flexors of the knee and hip. This instrument provides measurements in kilograms-force (kgf), which will be converted to Newton-meters (Nm) with correction of gravity. The proposed measure will be obtained before, immediately after intervention and one month after the intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Expected outcome: improved balance and gait parameters (walking speed, cadence, step length). The balance will be assessed using the Berg Bal ¬ ance Scale (BBS). It comprises 14 items that measure the static and dynamic balance in different situations. The running is evaluated by means of equipment GAITRite ® system. The GAITRite ® system consists of a mat with electronic sensors positioned to capture spatiotemporal measures of gait. All the proposed measures shall be obtained before, immediately after the intervention and one month after the intervention.;Expected outcome: improvement of clinical and functional performance and quality of life of individuals with PD. The UPDRS is a scale clinical evaluation of patients with PD and has four domains (mental activity, behavior and mood, activities of daily living, motor exploration and complications of drug treatment) which are evaluated in a semi-quantitative. All the proposed measures shall be obtained before, immediately after the intervention and one month after the intervention. The PDQ-39 indicates the overall impact of PD on the well-being and health of the individual as well as being sensitive to the effects of different treatments. | — |
Countries
Brazil
Contacts
Universidade Federal de Minas Gerais-UFMG